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Abstract
Objective: Our research article aimed to determine if six-month mortality amongst hepatitis B and C patients undergoing cardiac 
surgery varied according to gender, post-operatively. Secondarily, we highlighted the significant differences among the two genders 
in their pre-operative, operative, and post-operative characteristics and deduced significant predictors of mortality.
Methods: We obtained approval from the International Review Board of the Dow University of Health Sciences, and conducted a 
retrospective study targeting hepatitis B and C patients who had undergone cardiac surgery between January 2013 to October 2018 
at the Ruth Pfau Civil Hospital, Karachi, Pakistan. The data was analysed using the Statistical Package for Social Sciences (Version 
20.0). The population was divided into two groups, based on gender. Chi-squared test was used to compare categorical variables and 
odd ratios with 95% confidence interval were also computed. Differences in continuous variables were assessed using independent 
T-test or Mann-Whitney U test.
Results: There was no significant difference in six-month mortality between the genders, with a 22.5% mortality in males and 20.0% 
mortality in females. Post-operatively, males had higher creatinine (p=0.003) levels but females tended to have a longer ward stay 
(p=0.032). On multivariate logistic regression, duration of intubation (aOR=1.131, 95% CI: 1.002-1.275), cardiopulmonary bypass 
time (aOR=1.030, 95% CI: 1.002-1.059) and duration of ward stay (aOR=1.100, 95% CI: 1.031-1.175) were found to be significant 
predictors of mortality. 
Conclusion: There is no association between six-month mortality and gender among hepatitis B and C patients undergoing cardiac 
surgery. Additionally, duration of intubation, cardiopulmonary bypass time and duration of ward stay are significant predictors of six-
month mortality.
Keywords: Coronary artery bypass, coronary artery bypass, hepatitis B, hepatitis C, valvular heart disease.
INTRODUCTION
Chronic viral hepatitis is a debilitating condition, with 
approximately 400 million people being affected by the 
disease globally [1]. In Pakistan, 7.6% of the population 
is affected by hepatitis B and C, making it a disease 
which needs to be thoroughly researched [2]. Along with 
its direct effect on the liver, chronic viral hepatitis has 
been known to cause cardiovascular incidents owing 
to its’ longstanding impact on blood vessels, ultimately 
resulting in atherosclerosis [3, 4]. Furthermore, studies 
have revealed how hepatitis B and C have an impact 
on mortality along with increased postoperative 
complications, in cardiac surgery patients [5, 6].
Keeping in view the influence of chronic viral hepatitis on 
cardiac patients, another study revealed greater mortality 
in females compared to males after an acute myocardial 
infarction in a population affected by this condition [7]. An 
increased mortality and morbidity in females undergoing 
cardiac surgery has also been documented [8]. At the 
same time, the lack of a significant difference in mortality 
due to gender has been noted [9]. These contradictions 
make it important to resolve whether the outcome of 
cardiac surgery amongst chronic viral hepatitis patients 
varies according to gender, which will result in designing 
sex-specific post-operative interventions, ensuring 
minimal mortality in both males and females.
Considering the different outcomes of mentioned articles 
and lack of data, our primary objective was to investigate 
an association between post-operative six-month 
mortality, among a cohort of hepatitis patients undergoing 
cardiac surgery in a tertiary care hospital, and patient 
gender. Secondarily, we aimed to identify how pre-
operative, operative and post-operative characteristics 
differed between the two sexes. Furthermore, we aimed 
to assess the predictors of mortality in our population, 
thus adding to existing literature.
MATERIALS AND METHODS
A retrospective study was held in the city of Karachi, 
Pakistan at a tertiary care hospital over a period of six 
months from May to October 2018. The material was 
collected from the cardiac surgery ward at the Ruth 
Pfau Civil Hospital in Karachi, Pakistan. The data were 
obtained from discharge case files and extracted onto a 
standardised proforma which was obtained from senior 
doctors and customised according to our research. This 
study conforms to widely accepted ethical principles 
and was approved by the International Review Board 
of the Dow University of Health Sciences. Owing to the 
retrospective nature of our study, our ethical review board 
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allowed us to access contact details of the patients, 
through the discharge case files. After explaining the 
purpose of the research, we obtained consent from the 
patients over the telephone.
SELECTION AND DESCRIPTION OF 
PARTICIPANTS
A retrospective study was conducted where we included 
all patients with hepatitis virus infection who underwent 
elective cardiac surgery at the Dr. Ruth Pfau Civil 
Hospital, Karachi from January 2013 to October 2018. A 
total of one hundred and sixteen patients who underwent 
valve replacement surgery or coronary artery bypass 
grafting were included, with normal liver function. We 
used anticipated frequency of 2.6% [8], population size 
of 1 million, confidence interval of 95% and 4% precision 
to calculate our sample size using openepi.com, which 
came to 61. However, owing to the retrospective nature 
of our study, we had access to 116 patients in the given 
time frame. During data collection, we discarded all 
those files which had incomplete information, necessary 
for obtaining accurate results. Before the surgery was 
undertaken, the hepatitis profile, using PCR and other 
liver function tests were conducted.  Our exclusion criteria 
consisted of those patients who had an abnormal liver 
profile, owing to the impact it would have on immediate 
outcomes, to reduce sampling bias. Additionally, we 
also discarded the case files which didn’t have patient 
contact details, essential towards determining mortality 
at six months. The patient population encompassed all 
ages, ethnicity and religion.
TECHNICAL INFORMATION
The proforma was divided into four broad sections; 
patient information, pre-operative data, operative data 
and post-operative complications. 
The patient information included their name, gender, 
smoking history and history of co-morbidities, specifically 
mentioning hypertension, rheumatic heart disease, 
diabetes, obesity, chronic obstructive pulmonary disease, 
liver dysfunction and atrial fibrillation along with details 
regarding hepatitis profile. The section on pre-operative 
data included all relevant cardiac information such as 
left ventricular function, left atrium size, systolic and 
diastolic dimensions. Relevant echo findings pointing 
toward any form of regurgitation or stenosis were also 
noted, along with the number of diseased vessels.
Operative data included procedural details namely 
cardiopulmonary bypass time, cross-clamp time, the 
size of the prosthetic valves used for valve replacements 
and the number of grafts used for the coronary artery 
bypass grafting. Post-operative complications such as 
wound infection, reopening, atrial fibrillation, any need 
for synchronised shock, low cardiac output was also 
assessed.
We aimed to assess the outcome by taking certain 
parameters into consideration. Operative data such 
as the use of an inotrope and an intra-aortic balloon 
pump were noted to determine their consequence on 
mortality. Amongst post-operative data, duration of 
intubation, intensive care unit (ICU) stay, ward stay, the 
need for blood transfusions, along with post-operative 
haemoglobin and creatinine were used to assess 
outcome. We contacted patients through phone calls, to 
determine six-month mortality.
STATISTICAL ANALYSIS
Data was analysed using the Statistical Package for 
Social Sciences (SPSS) (version 20.0). Categorical 
variables were expressed using frequencies and 
percentages. Continuous variables were presented as 
mean ± standard deviations, or median (inter-quartile 
range) as appropriate. The study population was divided 
into two groups based on gender. Chi-squared test or 
Fisher-exact test was used to compare categorical 
variables between the two groups. Differences in 
continuous variables were assessed using independent 
T-test or Mann-Whitney U test, as appropriate. A 
univariate logistic regression was conducted to identify 
variables independently associated with mortality at 6 
months, and their crude odds ratios were calculated. 
Variables that had a near significant (p<0.20) effect 
influence on mortality were included in a multivariable 
model to produce adjusted odds ratios. A 5% level of 
significance was used throughout the study.
RESULTS
One hundred and sixteen patients with documented 
viral hepatitis infection were included in the analysis. 
The study cohort comprised of 74 (63.8%) males 
and 42 (36.2%) females. Baseline and pre-operative 
characteristics for these patients, stratified by gender, 
are shown in Table 1. The mean age for all patients 
was 41.58± 15.01 years, with a younger mean age 
among female subjects (p=0.002). Males (n=19, 25.7%) 
were more likely than females (n=1, 2.4%) to report a 
previous history of smoking (p=0.001). No gender-
specific differences were observed with respect to 
previous history of diabetes (p=0.804), previous history 
of myocardial infarction (p=0.097) or previous history of 
hypertension (p=0.704). Most patients were hepatitis 
C positive (n=86, 74.1), followed by hepatitis B (n=26, 
22.4) and combined hepatitis B and C (n=4, 3.4). Gender 
was not significantly associated with the type of hepatitis 
profile (p=0.306).
Female patients were more likely to display lower pre-
operative haemoglobin levels versus males (p<0.001). 
Males were more likely to present with a higher baseline 
creatinine, as compared to females (p<0.001). Most 
patients had a good (>60%) (n=46, 39.7%) to moderate 
(30-60%) (n=69, 59.5%) left ventricular ejection fraction 
(LVEF). Pre-operative assessments of LVEF (p=0.307), 
systolic dimension (p=0.172), mean diastolic dimension 
(p=0.584) and left atrial dimensions (p=0.160) were not 
significantly different among males and females (Table 1).
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Among the one hundred and sixteen patients undergoing 
cardiac surgery; 45 (38.8%) underwent coronary artery 
bypass grafting (CABG) and 62 (53.4%) underwent 
valve replacement surgery (Table 2). Females were 
more likely to receive a shorter aortic cross-clamp time, 
as opposed to males (p=0.018). 
Table 2 displays the operative characteristics of patients 
undergoing CABG (n=45) and valve replacement 
surgeries (n=62), respectively. The median number 
of diseased vessels and vessel grafts among patients 
undergoing CABG was 3 in each case. No significant 
difference in the number of diseased vessels was 
noted with respect to gender, however, females tended 
to receive fewer grafts than men (p=0.032). Patients 
undergoing valvular replacement included those 
suffering from mitral regurgitation (62.9%), mitral stenosis 
(66.1%), aortic regurgitation (41.9%), aortic stenosis 
(21.0%) and tricuspid regurgitation (64.5%). Types of 
valvular diseases did not significantly differ by gender. 
The mean size of implanted mitral (p=0.002) and aortic 
valves (p<0.001) was smaller in women versus men.
Post-operative haemoglobin levels did not significantly 
differ between the two groups (p=0.147) (Table 3). Post-
Table 1: Baseline and pre-operative study characteristics; stratified by gender.
Demographic Characteristic All Patients (n=116) Males (n=74) Females (n=42) p-value
Age (years) # 41.58± 15.01 44.73±14.542 36.02±14.338 **0.002
Body Mass Index (kg/m2) # 23.53± 5.41 24.01±5.37 22.68±5.44 0.207
Smoker (%) 20 (17.2) 19 (25.7) 1 (2.4) **0.001
History of Diabetes (%) 15 (12.9) 10 (13.5) 5 (11.9) 0.804
History of Myocardial Infarction (%) 7 (6.0) 2 (2.7) 5 (11.9) 0.097
History of Hypertension (%) 30 (25.9) 20 (27.0) 10 (23.8) 0.704
Hepatitis C (%) 86 (74.1) 52 (70.3) 34 (81.0)
0.306Hepatitis B (%) 26 (22.4) 18 (24.3) 8 (19.0)
Hepatitis B and C (%) 4 (3.4) 4 (5.4) 0 (0.0)
Good Left Ventricular Ejection Fraction (>60%) 46 (39.7) 26 (35.1) 20 (47.6)
0.307Moderate Left Ventricular Ejection Fraction (30-60%) 69 (59.5) 47 (63.5) 22 (52.4)
Poor Left Ventricular Ejection Fraction (<30%) 1 (0.9) 1 (1.4) 0 (0.0)
Body Mass Index (kg/m2) # 1.00 (0.70-1.10) 1.00 (0.80-1.20) 0.80 (0.60-1.00) **<0.001
Pre-operative Haemoglobin (g/dl) † 11.75 (9.60-13.00) 12.4 (11.0-13.5) 10.2 (8.2-11.6) **<0.001
Systolic Dimension † 35.00 (31.00-40.00) 36.00 (32.00-40.00) 35.00 (30.00-39.25) 0.172
Diastolic Dimension # 49.75± 9.04 50.11±8.65 49.14±9.76 0.584
Left Atrial Dimensions † 45.00 (37.00-50.00) 41.00 (36.50-49.50) 45.00 (39.75-55.00) 0.160
#: variables expressed as mean ± standard deviation, †: variables expressed as median (inter-quartile range).
*: denotes significant at p<0.05, **: denotes significant at p<0.01.
Table 2: Operative Characteristics of patients undergoing CABG and Valve Replacement surgery; stratified by gender.
Coronary Artery Bypass Grafting Details All Patients (n=45) Males (n=34) Females (n=11) p-value
No. of Vessels Diseased † 3.00 (3.00-3.00) 3.00 (3.00-3.00) 3.00 (2.00-3.00) 0.421
No. of Grafts † 3.00 (3.00-4.00) 3.00 (3.00-4.00) 3.00 (2.00-3.00) *0.032 
Valve Replacement Details All patients (n=62) Males (n=36) Females (n=26) p-value
Mitral Regurgitation 39 (62.9) 23 (63.9) 16 (61.5) 0.850
Mitral Stenosis 41 (66.1) 23 (63.9) 18 (69.2) 0.661
Aortic Regurgitation 26 (41.9) 17 (47.2) 9 (34.6) 0.321
Aortic Stenosis 13 (21.0) 7 (19.4) 6 (23.6) 0.729
Tricuspid Regurgitation 40 (64.5) 21 (58.3) 19 (73.1) 0.231
Mitral Valve Size # 30.429± 2.607 31.303± 2.506 29.174± 2.249 **0.002
Aortic Valve Size # 23.143± 2.413 24.556± 1.667 20.600± 0.894 **0.001
Mitral Valve Area † 1.200 (0.900-3.000) 1.175 (0.825-3.750) 1.250 (0.975-1.950) 0.536
#: variables expressed as mean ± standard deviation, †: variables expressed as median (inter-quartile range).
*: denotes significant at p<0.05, **: denotes significant at p<0.01.
Table 3: Post-operative study characteristics; stratified by gender.
Post-operative Characteristics All Patients (n=111) Males (n=74) Females (n=42) p-value
Post-operative Haemoglobin (g/dL) † 9.20 (8.30-10.40) 9.450 (8.500-10.575) 9.050 (8.075-9.925) 0.147
Post-operative Creatinine (mg/dL) † 0.90 (0.70-1.20) 1.000 (0.800-1.250) 0.750 (0.600-1.025) **0.003
Intensive Care Unit stay (days) † 2.00 (2.00-3.00) 2.50 (2.00-3.00) 2.00 (2.00-3.25) 0.673
Ward Stay (days) † 15.00 (11.00-22.00) 14.00 (10.00-21.00) 17.5 (12.00-26.00) **0.032
Six-month Mortality (%) 21.6 22.5 20.0 0.756
†: variables summarized as median (inter-quartile range).
Liaquat National Journal of Primary Care 2020; 2(1): 16-21 19
A Cohort of Gender-based Outcomes in Hepatitis B and C after Cardiac Surgery
operative creatinine levels were significantly higher 
in males (p=0.003). Female patients tended to have 
a longer duration of ward stay as compared to their 
male counterparts (p=0.032). No such association was 
noted with respect to duration of the ICU stay (p=0.673) 
(Table 3).
The overall 6-month mortality for the study cohort was 
21.6%. The unadjusted 6-month mortality rate was 
22.5% in males and 20.0% in females. This difference 
was not significant on univariate analysis (p=0.756). 
The logistic model predicting 6-month mortality is 
shown in Table 4. Univariate logistic regression revealed 
age, pre-operative creatinine (p=0.039), duration 
of intubation (p=0.001), inotrope use (0.041), aortic 
cross-clamp time (p=0.004), cardiopulmonary bypass 
time (p=0.002) and duration of ward stay (p=0.004) 
to be significantly associated with increased 6-month 
mortality, after the surgical procedure (Table 4). After 
performing multivariable logistic regression, only the 
following variables remained independently associated 
with increased six-month mortality: duration of intubation 
(p=0.046), cardiopulmonary bypass time (p=0.035) and 
duration of ward stay (p=0.004) (Table 4). Female gender 
was not significantly associated with an increased risk of 
atrial fibrillation (p=0.593).
DISCUSSION
Over the years, cardiac surgery has seen major 
advancements and immense research has been 
conducted in this field. Chronic viral hepatitis in itself is 
a major contributor to morbidity and mortality and has 
been known to have cardiovascular manifestations. 
Owing to this factor and a general lack in the existing 
literature, we felt a need to determine gender-based 
mortality and morbidity in hepatitis patients undergoing 
cardiac surgery [9].
In our population, we noticed females suffering from 
hepatitis at a younger age compared to males, findings 
which are consistent with a study conducted by 
MaleweKolou et al. [10]. As screening for viral hepatitis 
is a part of antepartum care, the condition is naturally 
detected sooner in females compared to males. As 
found in a study conducted in Kenya assessing gender 
differences in smoking, our study also noticed that men 
smoked more than women, possibly owing to society’s 
perception of smoking amongst women as inappropriate 
and unacceptable behaviour [11].
The preoperative profiles of both genders in terms of 
having a history of hypertension and myocardial infarction 
didn’t vary significantly which contrasts with a study 
where females had a greater incidence of hypertension 
and a lower incidence of myocardial infarction. In the 
same study, gender differences regarding diabetes were 
insignificant, a finding which was supported by our results 
as well [9]. Owing to our population having a mean age of 
forty-two years, the reason why we obtained insignificant 
findings in relation to the preoperative profiles could 
be that such conditions haven’t been yet diagnosed in 
our patients. According to our results, female patients 
displayed lower haemoglobin levels compared to males. 
As women are known to have mean haemoglobin levels 
which are 12% lower than age and race-matched men 
due to underlying physiological phenomenon, this is 
unsurprising [12]. Male patients presented with higher 
creatinine levels, in line with previous findings where 
females tend to have lower serum creatinine levels than 
men, when kidneys have similar function [13]. Salton CJ. 
et al. found no considerable differences of left ventricular 
ejection fraction between men and women; which is 
consistent with our findings [14]. Additionally, other 
modalities of pre-operative assessment also remained 
insignificant between the two genders.
Intra-operative characteristics were taken into 
consideration to assess morbidity. However, out of 
aortic cross-clamp time, duration of intubation, usage of 
inotropes and cardiopulmonary bypass time, only aortic 
cross-clamp time differed significantly between males 
and females, with females having a shorter cross-clamp 
time. These findings are consistent in a study conducted 
in Australia [15] but inconsistent with another study 
conducted in Saudi Arabia [16].
The population we were taking into consideration 
consisted of those undergoing cardiac bypass surgery 
or valve replacement surgeries. Our results displayed 
that most of the patients undergoing CABG were those 
who had triple vessel disease. This finding doesn’t come 
as a surprise as the preference of CABG over other 
treatment modalities such as percutaneous angiography, 
for triple vessel heart disease is well-documented [17]. 
Though we didn’t observe a difference in the number 
of diseased vessels according to gender, our results 
displayed that females received fewer grafts than men, 
reinforced by similar findings [16]. Studies researching 
outcome between genders have repeatedly noticed the 
Table 4: Univariate and multivariable logistic regression-predictors of six-month mortality.
Variable
Univariate Logistic Regression Multivariable Logistic Regression
Odds Ratio (95% CI) p-value Odds Ratio (95% CI) p-value
Age 1.045 (1.010-1.080) *0.010 1.050 (0.999 – 1.103) 0.053
Pre-operative Creatinine 4.667 (1.081-20.156) *0.039 4.703 (0.638 – 34.693) 0.129
Duration of Intubation 1.146 (1.058-1.242) **0.001 1.131 (1.002-1.275) *0.046
Inotrope Use 1.032 (1.001-1.064) *0.041 1.034 (0.992 – 1.078) 0.118
Aortic Cross-clamp Time 1.024 (1.008-1.041) **0.004 0.969 (0.928 – 1.012) 0.161
Cardiopulmonary Bypass Time 1.019 (1.007-1.032) **0.002 1.030 (1.002-1.059) *0.035
Duration of Ward Stay 1.068 (1.021-1.118) **0.004 1.100 (1.031-1.175) **0.004
CI: confidence interval, *: denotes significant at p<0.05, **: denotes significant at p<0.01.
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lesser use of the Left Internal Mammary Artery graft 
in women, which has ultimately led to worse outcome 
amongst women [18]. However, the varying number of 
grafts amongst the genders in our population seemingly 
had no effect on mortality, calling for further research 
regarding the relationship between graft number and 
outcome. 
Though a higher incidence of mitral valve stenosis and 
mitral valve prolapse, especially in younger women for 
the latter is observed, we noticed no such trend in our 
study [19]. Alternatively, the equal incidence of aortic 
valve stenosis between men and women is well- 
documented, like what we observed [19]. However, our 
female population tended to be implanted with a 
smaller prosthesis compared to males, possibly owing to 
the smaller Body Surface Area of females. A study 
investigating mortality in patients where a smaller 
prosthesis was used, also identified the female gen-
der and a lower body surface area as conditions where 
a smaller prosthesis was employed for aortic valve 
replacement [20].
Our results displayed higher post-operative creatinine 
levels in males compared to females, a finding which 
is in disparity with what has been seen in other studies 
[21]. Similarly, the literature also states that a higher 
post-operative creatinine level should lead to a greater 
duration of the ward stay. Our results differed in this point 
too as they showed a longer ward stay in females, who, 
in our study had lower post-operative creatinine levels 
compared to males [21].
The six-month mortality in our population was 21.6%, 
much higher compared to the 5% seen in a study 
conducted in the Netherlands [22] and the 3% seen in 
a study carried out in Egypt [23]. As our population hails 
from a poor socioeconomic background, factors such 
as late presentation, more co-morbidities, and a weaker 
immune system may all contribute to our findings. 
Regardless of the cause for such disparity, methods to 
ensure that public have adequate awareness concerning 
heart disease and how it presents, coupled with better 
treatment strategies, all need to be employed to lessen 
the worrisome mortality rate seen in our population. 
Our study showed no significant difference in mortality 
between males and females, all of whom were infected 
with hepatitis B, C or both. Our findings are in accordance 
with what was found in an Australian study aiming to 
assess the impact of gender on outcomes after cardiac 
surgery [9]. However, our study refutes what has been 
found in other studies which conclude that females tend 
to have greater morbidity [8]. Owing to these conflicting 
statements there is still a need to further investigate the 
impact of gender on mortality, amongst chronic viral 
hepatitis patients, especially in Pakistan where statistics 
show that nearly eight percent of the population is 
suffering from the condition [2].
Through our study, we also aimed to assess those factors 
which were significantly associated with greater six-
month mortality. Through univariate logistic regression, 
we identified age as being a predictor of mortality, 
which reinforces the findings outlined by a cohort 
which explored the differences in mortality between two 
populations, one ranging between 60-75 and one above 
75. A major reason contributing to the results in the 
mentioned study was how patients part of the younger 
age group tended to undergo elective surgery instead of 
emergency treatment, compared to the older age group, 
a factor which could have seriously impacted our study 
as well [24]. We identified longer aortic cross-clamp 
time and cardiopulmonary bypass time as predictors of 
mortality, both of which were also identified in a study 
conducted in Brazil, with inotrope use also joining the two 
as a predictor [25]. Unsurprisingly, prolonged intubation 
was also a significant predictor of mortality, the same 
result being demonstrated in other studies, where 
hospital mortality was significantly higher compared to 
that seen at one year. Despite this difference, there was 
still a marked difference in mortality at one year for those 
patients who underwent prolonged intubation compared 
to those who didn’t [26]. Interestingly we found ward stay 
to be a significant predictor of mortality, compared to 
prolonged ICU stay. Prolonged ward stay as a predictor 
is minimally researched, but those studies which have 
considered total length of stay (ICU and ward stay 
combined), have demonstrated its’ greater impact on 
mortality compared to an average length of hospital stay 
[27]. On multivariate logistic regression, the significant 
predictors of mortality were lessened, consisting of 
prolonged ward stay, cardiopulmonary bypass time and 
prolonged intubation. Increased cardiopulmonary bypass 
time has been identified as a predictor of mortality in 
other studies as well [28] and prolonged intubation has 
also been associated with longer ICU stay which can 
lead to greater chances of mortality [29].
CONCLUSION
Our study showed no significant difference in mortality 
for hepatitis patients, based on gender. However, our 
study outlined certain predictors of mortality such as 
prolonged intubation time, prolonged ward stays and 
cardiopulmonary bypass time, adding to the current 
literature regarding cardiac surgery and factors affecting 
its’ outcomes.
LIMITATIONS
This study was conducted in a single tertiary centre 
which limits the generalisability of our findings. Our 
study was limited due to the inclusion criteria employed. 
Furthermore, the sample was dominated by male 
subjects which may limit our ability to draw comparisons 
by gender. Despite these factors, our research provides 
vital insight in the outcomes observed after cardiac 
surgery.
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